Oppenheimer Raises Price target on The Advisory Board (ABCO) Following Investor Day

September 27, 2016 9:35 AM EDT
Get Alerts ABCO Hot Sheet
Price: $40.11 --0%

Rating Summary:
    13 Buy, 8 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 11 | New: 3
Trade ABCO Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Oppenheimer reiterated an Outperform rating on Advisory Board Company (NASDAQ: ABCO), and raised the price target to $49.00 (from $45.00), following the company's investor day. Oppenheimer came away from the event with a better understanding of the company's new Planning 20/20 and sales force reorganization initiatives.

Analyst Mohan Naidu commented, "We attended ABCO's annual investor day at its Washington D.C. headquarters yesterday. We came away with a better understanding of its new Planning 20/20 and sales force reorg initiatives, which should help lift CV in CY17. We also increased our confidence in the member value (ROI) derived on both the core healthcare and higher education sides. Our detailed note includes examples of research insights, innovative tools, and expectations for important healthcare trends such as valuebased payments and MACRA. We reiterate our Outperform rating, raising our target from $45 to $49, on 12x our CY17 Adj. EBITDA estimate (was 11x)."

For an analyst ratings summary and ratings history on Advisory Board Company click here. For more ratings news on Advisory Board Company click here.

Shares of Advisory Board Company closed at $43.41 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Add Your Comment